WEST PHARMACEUTICAL SERVICES, INC. (WST) /
The profitability of WEST PHARMACEUTICAL SERVICES, INC. over the past 10 years
Chart WEST PHARMACEUTICAL SERVICES, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →WEST PHARMACEUTICAL SERVICES, INC. reported net income of $493.7M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $1.1B and operating income of $584.9M. It reported a profit in all 10 years shown. Its highest net income in these years was $661.8M, in fiscal 2021.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.1B | $584.9M | $493.7M |
| 2024ended Dec 31, 2024 | $998.5M | $569.9M | $492.7M |
| 2023ended Dec 31, 2023 | $1.13B | $676M | $593.4M |
| 2022ended Dec 31, 2022 | $1.14B | $734M | $585.9M |
| 2021ended Dec 31, 2021 | $1.18B | $752.3M | $661.8M |
| 2020ended Dec 31, 2020 | $767.8M | $406.9M | $346.2M |
| 2019ended Dec 31, 2019 | $605.7M | $296.6M | $241.7M |
| 2018ended Dec 31, 2018 | $545.4M | $240.3M | $206.9M |
| 2017ended Dec 31, 2017 | $512.9M | $225.8M | $150.7M |
| 2016ended Dec 31, 2016 | $501.4M | $195.2M | $143.6M |
Fiscal years as WEST PHARMACEUTICAL SERVICES, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on WEST PHARMACEUTICAL SERVICES, INC.
- The revenue of WEST PHARMACEUTICAL SERVICES, INC.
- The cash flow of WEST PHARMACEUTICAL SERVICES, INC.
- The debt of WEST PHARMACEUTICAL SERVICES, INC.
- The dividends of WEST PHARMACEUTICAL SERVICES, INC.
- All of WEST PHARMACEUTICAL SERVICES, INC.'s financials, charted
Companies of a similar size
- AWKAMERICAN WATER WORKS COMPANY, INC.
- CFGCITIZENS FINANCIAL GROUP INC/RI
- FTITechnipFMC plc
- TCOMTrip.com Group Limited
- FLEXFLEX LTD.
Not investment advice. This page shows what WEST PHARMACEUTICAL SERVICES, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.